9781563952692-1563952696-Blood Transfusion Therapy: A Physician's Handbook, 9th edition (AABB, Blood Transfusion Therapy)

Blood Transfusion Therapy: A Physician's Handbook, 9th edition (AABB, Blood Transfusion Therapy)

ISBN-13: 9781563952692
ISBN-10: 1563952696
Edition: 9
Author: Jerome Gottschall, Karen E., M.D. King
Publication date: 2008
Publisher: American Association of Blood Banks (AABB)
Format: Paperback 236 pages
FREE US shipping

Book details

ISBN-13: 9781563952692
ISBN-10: 1563952696
Edition: 9
Author: Jerome Gottschall, Karen E., M.D. King
Publication date: 2008
Publisher: American Association of Blood Banks (AABB)
Format: Paperback 236 pages

Summary

Blood Transfusion Therapy: A Physician's Handbook, 9th edition (AABB, Blood Transfusion Therapy) (ISBN-13: 9781563952692 and ISBN-10: 1563952696), written by authors Jerome Gottschall, Karen E., M.D. King, was published by American Association of Blood Banks (AABB) in 2008. With an overall rating of 4.4 stars, it's a notable title among other books. You can easily purchase or rent Blood Transfusion Therapy: A Physician's Handbook, 9th edition (AABB, Blood Transfusion Therapy) (Paperback) from BooksRun, along with many other new and used books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.41.

Description

Blood Transfusion Therapy: A Physician s Handbook has been thoroughly reviewed and revised to reflect state-of-the-art transfusion medicine practices. The book is intended to serve as a convenient reference for issues relating to transfusion medicine.

Featured in this edition:

Comprehensive review of blood component therapy.
Expanded discussion of plasma derivatives including factor concentrates and Rh Immune Globulin.
Revised obstetric, neonatal and pediatric transfusion practices with review of hemolytic disease of the fetus and newborn, intrauterine transfusion, exchange transfusion, and transfusion of preterm/neonatal infants and children.
Detailed discussion on diagnosis and treatment of von Willebrand disease, hemophilia A, hemophilia B, and on specific coagulation factor inhibitors.
Discussion on acquired bleeding conditions including vitamin K antagonism, dilutional coagulopathy, and liver disease.
Expanded discussion on the use of medications to reverse vitamin K antagonists, and for use of prohemostatic agents such as DDAVP, antifibrinolytic drugs, and recombinant Factor VIIa.
Review of hematopoietic progenitor cell therapy.
Updated apheresis indication lists based on the most recent ASFA guidelines

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book